Logo image of CKI.CA

CLARKE INC (CKI.CA) Stock Fundamental Analysis

TSX:CKI - Toronto Stock Exchange - CA1819013071 - Common Stock - Currency: CAD

22.35  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CKI. CKI was compared to 83 industry peers in the Capital Markets industry. While CKI is still in line with the averages on profitability rating, there are concerns on its financial health. CKI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CKI had positive earnings in the past year.
In the past year CKI had a positive cash flow from operations.
CKI had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CKI reported negative operating cash flow in multiple years.
CKI.CA Yearly Net Income VS EBIT VS OCF VS FCFCKI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

1.2 Ratios

CKI's Return On Assets of 5.08% is fine compared to the rest of the industry. CKI outperforms 76.19% of its industry peers.
CKI has a better Return On Equity (9.32%) than 79.76% of its industry peers.
The Return On Invested Capital of CKI (2.64%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CKI is significantly below the industry average of 8.66%.
The last Return On Invested Capital (2.64%) for CKI is above the 3 year average (1.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.08%
ROE 9.32%
ROIC 2.64%
ROA(3y)1.97%
ROA(5y)1.86%
ROE(3y)3.61%
ROE(5y)2.97%
ROIC(3y)1.65%
ROIC(5y)N/A
CKI.CA Yearly ROA, ROE, ROICCKI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

CKI has a Profit Margin of 32.10%. This is in the better half of the industry: CKI outperforms 77.38% of its industry peers.
CKI's Operating Margin of 24.16% is in line compared to the rest of the industry. CKI outperforms 52.38% of its industry peers.
In the last couple of years the Operating Margin of CKI has declined.
With a decent Gross Margin value of 42.55%, CKI is doing good in the industry, outperforming 67.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CKI has declined.
Industry RankSector Rank
OM 24.16%
PM (TTM) 32.1%
GM 42.55%
OM growth 3YN/A
OM growth 5Y-10.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.7%
GM growth 5Y-10.19%
CKI.CA Yearly Profit, Operating, Gross MarginsCKI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

3

2. Health

2.1 Basic Checks

CKI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CKI has more shares outstanding
Compared to 1 year ago, CKI has an improved debt to assets ratio.
CKI.CA Yearly Shares OutstandingCKI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CKI.CA Yearly Total Debt VS Total AssetsCKI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that CKI is in the distress zone and has some risk of bankruptcy.
CKI's Altman-Z score of 1.24 is fine compared to the rest of the industry. CKI outperforms 64.29% of its industry peers.
The Debt to FCF ratio of CKI is 83.90, which is on the high side as it means it would take CKI, 83.90 years of fcf income to pay off all of its debts.
CKI has a Debt to FCF ratio of 83.90. This is in the better half of the industry: CKI outperforms 66.67% of its industry peers.
CKI has a Debt/Equity ratio of 0.63. This is a neutral value indicating CKI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, CKI perfoms like the industry average, outperforming 55.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 83.9
Altman-Z 1.24
ROIC/WACCN/A
WACCN/A
CKI.CA Yearly LT Debt VS Equity VS FCFCKI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.20 indicates that CKI may have some problems paying its short term obligations.
CKI has a Current ratio of 0.20. This is amonst the worse of the industry: CKI underperforms 82.14% of its industry peers.
CKI has a Quick Ratio of 0.20. This is a bad value and indicates that CKI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.20, CKI is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
CKI.CA Yearly Current Assets VS Current LiabilitesCKI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 998.68% over the past year.
CKI shows a decrease in Revenue. In the last year, the revenue decreased by -1.92%.
The Revenue has been growing by 46.02% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)998.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%770.23%
Revenue 1Y (TTM)-1.92%
Revenue growth 3Y28.05%
Revenue growth 5Y46.02%
Sales Q2Q%4.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CKI.CA Yearly Revenue VS EstimatesCKI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CKI.CA Yearly EPS VS EstimatesCKI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.07, which indicates a correct valuation of CKI.
CKI's Price/Earnings is on the same level as the industry average.
CKI is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.07
Fwd PE N/A
CKI.CA Price Earnings VS Forward Price EarningsCKI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CKI is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CKI is valued a bit cheaper than 69.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 157.07
EV/EBITDA 16.32
CKI.CA Per share dataCKI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CKI!.
Industry RankSector Rank
Dividend Yield N/A

CLARKE INC

TSX:CKI (3/7/2025, 7:00:00 PM)

22.35

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-05 2025-03-05
Earnings (Next)05-08 2025-05-08
Inst Owners12.81%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap311.78M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.07
Fwd PE N/A
P/S 4.2
P/FCF 157.07
P/OCF 20.65
P/B 1.22
P/tB 1.22
EV/EBITDA 16.32
EPS(TTM)1.71
EY7.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.14
FCFY0.64%
OCF(TTM)1.08
OCFY4.84%
SpS5.32
BVpS18.32
TBVpS18.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.08%
ROE 9.32%
ROCE 4.29%
ROIC 2.64%
ROICexc 2.64%
ROICexgc 2.64%
OM 24.16%
PM (TTM) 32.1%
GM 42.55%
FCFM 2.67%
ROA(3y)1.97%
ROA(5y)1.86%
ROE(3y)3.61%
ROE(5y)2.97%
ROIC(3y)1.65%
ROIC(5y)N/A
ROICexc(3y)1.66%
ROICexc(5y)N/A
ROICexgc(3y)1.66%
ROICexgc(5y)N/A
ROCE(3y)2.7%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-17.95%
ROICexc growth 3YN/A
ROICexc growth 5Y-17.95%
OM growth 3YN/A
OM growth 5Y-10.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.7%
GM growth 5Y-10.19%
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 83.9
Debt/EBITDA 5.68
Cap/Depr 126.1%
Cap/Sales 17.67%
Interest Coverage 250
Cash Conversion 53.28%
Profit Quality 8.33%
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z 1.24
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)78.54%
Cap/Depr(5y)59.35%
Cap/Sales(3y)13.46%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)998.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%770.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.92%
Revenue growth 3Y28.05%
Revenue growth 5Y46.02%
Sales Q2Q%4.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.45%
EBIT growth 3YN/A
EBIT growth 5Y31.07%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.76%
OCF growth 3YN/A
OCF growth 5Y-7.37%